SharpyGLP-1 and Crohn's Disease or Ulcerative Colitis: The Evidence
Most people with Crohn's disease or ulcerative colitis can take a GLP-1 like semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro) if their GI doctor agrees, and 2026 studies have not found that these drugs trigger more flares. Some studies link them to fewer steroids and hospital stays, but the largest 2026 analysis found no real protection against relapse, so they are not an IBD treatment. Plan for protein, because a smaller appetite plus IBD raises the risk of losing muscle; Sharpy gives you one daily protein target to aim for.
Can you take a GLP-1 drug if you have Crohn's disease or ulcerative colitis? For most people the answer is yes, with your GI doctor in the loop. Studies of semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) in people with inflammatory bowel disease (IBD) have not found more flares, more surgery or new safety problems. Some studies even link GLP-1 use to fewer steroid courses and fewer hospital stays. But the biggest 2026 analysis found no real protection against relapse, so a GLP-1 is a weight or diabetes medicine, not an IBD treatment.
This guide walks through what the newest research found, what the labels say, and how to eat and train so you lose fat without losing the muscle IBD already puts at risk.
GLP-1 and Crohn's disease: why the question is everywhere
More people with IBD now live with obesity or type 2 diabetes, so more of them are being offered a GLP-1. At the same time, GLP-1 receptors are found in the gut, and lab studies suggest GLP-1 signals may calm gut inflammation. That made researchers ask a hopeful question: could these drugs help IBD itself? A new wave of 2026 studies tried to answer it, and the news keeps covering them.
What the 2026 studies found
Here is a plain reading of the main studies. All of them are observational, which means they compare people who chose to take a GLP-1 with similar people who did not. They can show a link, not a cause.
| Study | Who was studied | What it found | Main limit |
|---|---|---|---|
| Clinical Gastroenterology and Hepatology, July 2026 (OptumLabs claims, 2018 to 2023) | Adults with stable Crohn's or UC plus obesity or diabetes who started semaglutide or tirzepatide | 1-year relapse: 7.9% vs 7.9% in milder disease; 12.4% vs 15.6% on advanced therapy (not a significant difference). No extra safety problems | No scope or lab data; many people stopped the GLP-1 within a year |
| Crohn's & Colitis Congress, January 2026 (TriNetX) | 546 adults with Crohn's and overweight or obesity on a GLP-1, matched to 546 non-users | Steroid dependence 52.9% vs 62.8%; hospital stays 2.3% vs 3.7% at 12 months; surgery rates similar | Conference abstract, observational |
| Inflammatory Bowel Diseases, 2026 | 150 adults with UC who started liraglutide or semaglutide, matched to 150 non-users | Symptom remission at 12 weeks: 66.7% vs 25.3% | Small, observational, symptom-based |
| ACG meeting, October 2024 (TriNetX) | 2,204 adults with UC and obesity on a GLP-1, matched to 2,204 non-users | Lower odds of death, hospital stays, steroid use and gut complications over 5 years | Poster, observational |
The honest summary: the drugs look safe in IBD, and some signals look good. But the most careful study, which tried to copy a real trial, found no clear drop in relapses. Its authors wrote that current evidence does not support GLP-1s as disease-modifying therapy for IBD. Randomized trials are the next step.
One more detail from that July study matters for real life. About half of people with milder IBD, and about 4 in 10 on advanced therapy, stopped the GLP-1 within a year. About a quarter stopped within three months. Stomach side effects are a common reason people quit these drugs.
Can you take a GLP-1 with Crohn's disease?
No GLP-1 label lists Crohn's disease or ulcerative colitis as a reason not to use it. What the labels do say:
- Wegovy (semaglutide): use has been linked to stomach and gut side effects, sometimes severe. Wegovy is not recommended in people with severe gastroparesis (a very slow stomach).
- Zepbound (tirzepatide): tirzepatide has not been studied in people with severe gastrointestinal disease, including severe gastroparesis, and is not recommended for them.
- Both families of drugs list ileus (a bowel that stops moving) among problems reported after approval.
That is why the "it depends" part of the answer matters. Bring these questions to your GI doctor before you start:
- Is my IBD in remission right now, or active?
- Do I have a stricture (a narrowed part of the bowel) or a history of blockage?
- Will a slower stomach change how my oral IBD medicines work?
- How will we tell a GLP-1 side effect apart from a flare?
Never stop, skip or change an IBD medicine because you started a GLP-1. Decisions about dose and timing belong to your prescriber.
Side effect or flare? How to tell them apart
GLP-1 side effects overlap with IBD symptoms. Nausea, diarrhea, belly pain and bloating can come from either one. A few patterns can help you describe what is happening to your doctor:
| Sign | More typical of GLP-1 side effects | Call your GI doctor promptly |
|---|---|---|
| Timing | Starts in the first days after a dose or a dose increase, then eases | Builds over days and does not ease |
| Stool | Loose stool or constipation, no blood | Blood or mucus in stool, many urgent trips a day |
| Pain | Mild cramping or fullness after eating | Strong, steady pain, swelling or pain with fever |
| Eating | Full fast, mild nausea | Vomiting, cannot keep fluids down |
Severe belly pain that spreads to your back, vomiting that will not stop, a swollen belly with no stool or gas, or signs of dehydration need urgent care, whatever the cause. Our guide to GLP-1 and pancreatitis covers the pain pattern doctors worry about most.
Why muscle is the real risk with IBD on a GLP-1
People with IBD already have a higher chance of poor nutrition and low muscle mass. Inflammation, flares, diet limits and steroids all work against muscle. A GLP-1 then shrinks appetite on top of that. Eat too little protein, and a good share of the weight you lose can come from muscle instead of fat.
Three habits help:
- Protein first. Start each meal with the protein part. Our protein target guide explains how much most adults on a GLP-1 need.
- Lift something. Two or three short strength sessions a week tell your body to keep its muscle.
- Watch the trend, not the scale. Losing fast while feeling weak is a sign to tell your doctor and eat more protein.
This is where Sharpy helps: it turns all of that into one daily protein target, one 20-minute workout and one Shape Score, so you can see if you are losing fat while keeping muscle.
What to eat on a GLP-1 with Crohn's or colitis
Standard GLP-1 food advice needs a few changes when you have IBD:
- Small, soft, protein-rich meals. Eggs, Greek yogurt (if dairy agrees with you), fish, chicken, tofu and protein shakes are easy on a slow stomach.
- Fiber with care. Most GLP-1 users are told to eat more fiber, as in our fiber on GLP-1 guide. With a stricture or during a flare, many GI doctors advise limiting rough fiber like raw vegetables, nuts and seeds. Follow your own care team here.
- Fluids all day. Diarrhea from IBD plus a smaller thirst on a GLP-1 is a fast route to dehydration.
- Vitamins and iron. IBD and smaller meals can both lower iron, B12 and vitamin D. Our guide to Ozempic vitamin deficiency lists the blood tests to ask about.
- Trigger foods. Greasy, fried and very sugary foods tend to worsen both GLP-1 nausea and IBD symptoms.
If constipation is your issue instead, our constipation on GLP-1 guide has steps to discuss with your doctor, but check with your GI team before using laxatives with Crohn's disease.
Who should be extra careful
Talk to your GI doctor before starting, and expect closer follow-up, if you:
- Have active, moderate or severe IBD right now
- Have a stricture, a past blockage or a recent bowel surgery
- Have severe gastroparesis
- Are underweight, losing weight without trying, or have a history of an eating disorder
- Are pregnant, planning pregnancy or under 18
The bottom line
A GLP-1 can be a reasonable choice for weight or blood sugar if you have Crohn's disease or ulcerative colitis, and 2026 research has been reassuring about safety. It is not a treatment for IBD, and the hopeful findings still need real trials. Keep your GI doctor involved, learn the difference between a side effect and a flare, and make protein and strength training the center of your plan. To keep your protein and workouts on track while you lose fat, not muscle, try Sharpy.
Sources
- AGA News: GLP-1 drugs don't lower IBD relapse but appear safe, study finds (Jul 17, 2026)
- AGA News: GLP-1 therapy in Crohn's disease: fewer steroids, hospitalizations (Jan 22, 2026)
- Epocrates: GLP-1s linked to higher remission rates in ulcerative colitis (2026)
- Managed Healthcare Executive: GLP-1 benefits for people with ulcerative colitis and obesity (Nov 6, 2024)
- Wegovy prescribing information (FDA)
- Lilly Medical: Can Zepbound (tirzepatide) be used in patients with gastroparesis?
Questions people ask
Can you take a GLP-1 if you have Crohn's disease?
Many people with Crohn's disease take GLP-1 drugs, and studies so far have not shown more flares or more surgery. The decision belongs to you, your GI doctor and your prescriber together, especially if you have a narrowed bowel (stricture) or active disease.
Do GLP-1 drugs help ulcerative colitis?
Some observational studies found better symptoms and fewer steroids in people with ulcerative colitis who took semaglutide or liraglutide. These studies cannot prove cause and effect. No GLP-1 is approved to treat ulcerative colitis, and you should not stop or change IBD medicine because of a GLP-1.
Can Ozempic cause a Crohn's flare?
Large 2026 studies did not find more relapses in people with stable IBD who started semaglutide or tirzepatide. But GLP-1 side effects like nausea, diarrhea and belly pain can look like a flare, so tell your GI doctor about new or worse symptoms instead of guessing.
Is a GLP-1 a treatment for IBD?
No. GLP-1 drugs are approved for type 2 diabetes, weight management and some heart, kidney and liver uses. A July 2026 study in Clinical Gastroenterology and Hepatology concluded that current evidence does not support them as disease-modifying therapy for IBD. Trials are needed.
Is Zepbound safe with ulcerative colitis?
The Zepbound label does not list ulcerative colitis as a reason to avoid it. It says tirzepatide has not been studied in severe gastrointestinal disease and is not recommended in those patients. Whether your colitis counts as severe is a question for your GI doctor.
What should I eat on a GLP-1 with Crohn's or colitis?
Put protein first at every meal, eat small portions and drink fluids through the day. Fiber advice differs with IBD: people with strictures or active flares are often told to limit rough fiber, so follow your GI doctor or dietitian on that part.